Cargando…
Immune classification of osteosarcoma
Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSO...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992873/ https://www.ncbi.nlm.nih.gov/pubmed/33757216 http://dx.doi.org/10.3934/mbe.2021098 |
_version_ | 1783669469193699328 |
---|---|
author | Le, Trang Su, Sumeyye Shahriyari, Leili |
author_facet | Le, Trang Su, Sumeyye Shahriyari, Leili |
author_sort | Le, Trang |
collection | PubMed |
description | Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSORTx, to obtain the relative abundance of 22 immune cells. Then we cluster patients based on their estimated immune abundance and study the characteristics of these clusters, along with the relationship between immune infiltration and outcome of patients. We find that abundance of CD8 T cells, NK cells and M1 Macrophages have a positive association with prognosis, while abundance of γδ T cells, Mast cells, M0 Macrophages and Dendritic cells have a negative association with prognosis. Accordingly, the cluster with the lowest proportion of CD8 T cells, M1 Macrophages and highest proportion of M0 Macrophages has the worst outcome among clusters. By grouping patients with similar immune patterns, we are also able to suggest treatments that are specific to the tumor microenvironment. |
format | Online Article Text |
id | pubmed-7992873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-79928732021-03-25 Immune classification of osteosarcoma Le, Trang Su, Sumeyye Shahriyari, Leili Math Biosci Eng Article Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSORTx, to obtain the relative abundance of 22 immune cells. Then we cluster patients based on their estimated immune abundance and study the characteristics of these clusters, along with the relationship between immune infiltration and outcome of patients. We find that abundance of CD8 T cells, NK cells and M1 Macrophages have a positive association with prognosis, while abundance of γδ T cells, Mast cells, M0 Macrophages and Dendritic cells have a negative association with prognosis. Accordingly, the cluster with the lowest proportion of CD8 T cells, M1 Macrophages and highest proportion of M0 Macrophages has the worst outcome among clusters. By grouping patients with similar immune patterns, we are also able to suggest treatments that are specific to the tumor microenvironment. 2021-02-22 /pmc/articles/PMC7992873/ /pubmed/33757216 http://dx.doi.org/10.3934/mbe.2021098 Text en This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) |
spellingShingle | Article Le, Trang Su, Sumeyye Shahriyari, Leili Immune classification of osteosarcoma |
title | Immune classification of osteosarcoma |
title_full | Immune classification of osteosarcoma |
title_fullStr | Immune classification of osteosarcoma |
title_full_unstemmed | Immune classification of osteosarcoma |
title_short | Immune classification of osteosarcoma |
title_sort | immune classification of osteosarcoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992873/ https://www.ncbi.nlm.nih.gov/pubmed/33757216 http://dx.doi.org/10.3934/mbe.2021098 |
work_keys_str_mv | AT letrang immuneclassificationofosteosarcoma AT susumeyye immuneclassificationofosteosarcoma AT shahriyarileili immuneclassificationofosteosarcoma |